UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) Model for Breast Cancer Risk Prediction in Women With Atypical Hyperplasia

Journal of clinical oncology, 2010-08, Vol.28 (22), p.3591-3596

2010

Volltextzugriff (PDF)

Efficacy of Contralateral Prophylactic Mastectomy in Women With a Personal and Family History of Breast Cancer

Journal of clinical oncology, 2001-10, Vol.19 (19), p.3938-3943

2001

Volltextzugriff (PDF)

Stratification of Breast Cancer Risk in Women With Atypia: A Mayo Cohort Study

Journal of clinical oncology, 2007-07, Vol.25 (19), p.2671-2677

2007

Volltextzugriff (PDF)

Satisfaction After Contralateral Prophylactic Mastectomy: The Significance of Mastectomy Type, Reconstructive Complications, and Body Appearance

Journal of clinical oncology, 2005-11, Vol.23 (31), p.7849-7856

2005

Volltextzugriff (PDF)

Assessment of the Accuracy of the Gail Model in Women With Atypical Hyperplasia

Journal of clinical oncology, 2008-11, Vol.26 (33), p.5374-5379

2008

Volltextzugriff (PDF)

Model for individualized prediction of breast cancer risk after a benign breast biopsy

Journal of clinical oncology, 2015-03, Vol.33 (8), p.923-929

2015

Volltextzugriff (PDF)

Model for Predicting Breast Cancer Risk in Women With Atypical Hyperplasia

Journal of clinical oncology, 2018-06, Vol.36 (18), p.1840-1846

2018

Volltextzugriff (PDF)

Novel Breast Tissue Feature Strongly Associated With Risk of Breast Cancer

Journal of clinical oncology, 2009-12, Vol.27 (35), p.5893-5898

2009

Volltextzugriff (PDF)

Unhealthy alcohol use and toxicity of concurrent chemoradiation for head and neck cancer

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e17559-e17559

2019

Volltextzugriff (PDF)

Paclitaxel + ramucirumab versus paclitaxel alone in patients with squamous-cell carcinoma of the esophagus, refractory or intolerant to combination therapy with fluoropyrimidine and platinum-based drugs: Final results from the randomized phase 2 IKF-S627/RAMOS trial of the AIO

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e16043-e16043

2023

Volltextzugriff (PDF)

Risk of breast or ovarian cancer in family members who do not carry the BRCA1 or BRCA2 family mutation: Findings from the EMBRACE study

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.1558-1558

2017

Volltextzugriff (PDF)

Assessing cancer programs' financial resources for rural cancer patients

Journal of clinical oncology, 2019-09, Vol.37 (27_suppl), p.165-165

2019

Volltextzugriff (PDF)

A new model for predicting breast cancer risk in women with atypical hyperplasia

Journal of clinical oncology, 2015-10, Vol.33 (28_suppl), p.2-2

2015

Volltextzugriff (PDF)

Gene signature model for breast cancer risk prediction for women with sclerosing adenosis

Journal of clinical oncology, 2015-10, Vol.33 (28_suppl), p.18-18

2015

Volltextzugriff (PDF)

Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients

Journal of clinical oncology, 1994-06, Vol.12 (6), p.1272-1280

1994

Volltextzugriff (PDF)

Quantitation of CD11c+ dendritic cells normal breast tissue and benign breast disease

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e22115-e22115

2015

Volltextzugriff (PDF)

Impact of reconstruction on satisfaction with contralateral prophylactic mastectomy

Journal of clinical oncology, 2011-09, Vol.29 (27_suppl), p.240-240

2011

Volltextzugriff (PDF)

Tamoxifen and risk of contralateral breast cancer for \textitBRCA1 and \textitBRCA2 mutation carriers

Journal of clinical oncology, 2013, Vol.31, p.3091-9

2013

Volltextzugriff (PDF)

Targeting hyaluronan (HA) in tumor stroma: A phase I study to evaluate the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of pegylated hyaluronidase (PEGPH20) in patients with solid tumors

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.2579-2579

2012

Volltextzugriff (PDF)

Performance of the Gail model in individual women with benign breast disease

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.1525-1525

2011

Volltextzugriff (PDF)

A noncomparative randomized phase II study of two dose levels of itraconazole in men with metastatic castration-resistant prostate cancer (mCRPC): A DOD/PCCTC trial

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.4532-4532

2011

Volltextzugriff (PDF)

Effect of germ-line BRCA mutations in biochemical relapse and survival after treatment for localized prostate cancer

Journal of clinical oncology, 2013-02, Vol.31 (6_suppl), p.29-29

2013

Volltextzugriff (PDF)

In Reply

Journal of clinical oncology, 2008-09, Vol.26 (27), p.4515-4515

2008

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library All Journals

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(34)

Sprache

Englisch
(34)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(14)
Oncology
(14)
Science & Technology
(14)
Humans
(13)
Female
(11)
Middle Aged
(11)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Aged
(9)
Adult
(8)
Tumors
(7)
Follow-Up Studies
(6)
Original Reports
(6)
Breast Neoplasms - Pathology
(5)
Risk Factors
(5)
Adolescent
(4)
Aged, 80 And Over
(4)
Breast Neoplasms - Prevention & Control
(4)
Breast - Pathology
(3)
Breast Neoplasms - Genetics
(3)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) Model for Breast Cancer Risk Prediction in Women With Atypical Hyperplasia

Efficacy of Contralateral Prophylactic Mastectomy in Women With a Personal and Family History of Breast Cancer

Stratification of Breast Cancer Risk in Women With Atypia: A Mayo Cohort Study

Germline BRCA Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer

Satisfaction After Contralateral Prophylactic Mastectomy: The Significance of Mastectomy Type, Reconstructive Complications, and Body Appearance

Assessment of the Accuracy of the Gail Model in Women With Atypical Hyperplasia

Model for individualized prediction of breast cancer risk after a benign breast biopsy

Model for Predicting Breast Cancer Risk in Women With Atypical Hyperplasia

Novel Breast Tissue Feature Strongly Associated With Risk of Breast Cancer

Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

Unhealthy alcohol use and toxicity of concurrent chemoradiation for head and neck cancer

Paclitaxel + ramucirumab versus paclitaxel alone in patients with squamous-cell carcinoma of the esophagus, refractory or intolerant to combination therapy with fluoropyrimidine and platinum-based drugs: Final results from the randomized phase 2 IKF-S627/RAMOS trial of the AIO

Risk of breast or ovarian cancer in family members who do not carry the BRCA1 or BRCA2 family mutation: Findings from the EMBRACE study

Assessing cancer programs' financial resources for rural cancer patients

A new model for predicting breast cancer risk in women with atypical hyperplasia

Gene signature model for breast cancer risk prediction for women with sclerosing adenosis

Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients

Quantitation of CD11c+ dendritic cells normal breast tissue and benign breast disease

Impact of reconstruction on satisfaction with contralateral prophylactic mastectomy

Tamoxifen and risk of contralateral breast cancer for \textitBRCA1 and \textitBRCA2 mutation carriers

Targeting hyaluronan (HA) in tumor stroma: A phase I study to evaluate the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of pegylated hyaluronidase (PEGPH20) in patients with solid tumors

Performance of the Gail model in individual women with benign breast disease

A noncomparative randomized phase II study of two dose levels of itraconazole in men with metastatic castration-resistant prostate cancer (mCRPC): A DOD/PCCTC trial

Effect of germ-line BRCA mutations in biochemical relapse and survival after treatment for localized prostate cancer

In Reply

Aktive Filter

Suchergebnisse filtern